Paul R. Forfia

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography”.

Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography

Journal of Clinical Medicine(2022)10.3390/jcm11144034

N/A

0.442DataRank · unranked

18 citations

Hussein J. Hassan, Mario Naranjo, Alessandra Cuomo, Jeremy A. Mazurek, Paul R. Forfia +9 more

Effects of ranolazine on right ventricular function, fluid dynamics, and metabolism in patients with precapillary pulmonary hypertension: insights from a longitudinal, randomized, double-blinded, placebo controlled, multicenter study

Frontiers in Cardiovascular Medicine(2023)10.3389/fcvm.2023.1118796

N/A

0.396DataRank · unranked

13 citations

Paul R. Forfia, Anjali Vaidya, Gautam Ramani, Robert A. deKemp, Robert H. Mach +7 more

Ranolazine Improves Right Ventricular Function in Patients With Precapillary Pulmonary Hypertension: Results From a Double-Blind, Randomized, Placebo-Controlled Trial

Journal of Cardiac Failure(2020)10.1016/j.cardfail.2020.10.006

N/A

0DataRank · unranked

44 citations

Paul R. Forfia, Anjali Vaidya, Jeremy A. Mazurek, Myung H. Park, Gautam Ramani +3 more